Assessment of Myocardial Scar; Comparison between F-FDG PET, CMR and Tc-Sestamibi
Objective Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compa...
Main Authors: | Andrew Crean, Sadia N. Khan, L. Ceri Davies, Richard Coulden, David P. Dutka |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-01-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.4137/CMC.S730 |
Similar Items
-
Scar sarcoidosis on 18F-FDG PET/CT
by: Saurabh Arora, et al.
Published: (2019-06-01) -
Bone metastasis on Tc99-m sestamibi myocardial perfusion scan
by: Lachin Hatemi, MD, et al.
Published: (2014-01-01) -
Correlation between T2-weighted CMR and Sestamibi-SPECT in acute myocardial infarction and acute coronary occlusion
by: Schömig Albert, et al.
Published: (2009-01-01) -
Scar sarcoidosis: A rare entity found by 18F-FDG-PET/CT
by: M. Vidal, MD, PhD, et al.
Published: (2018-12-01) -
The role of 18F-FCH PET/CT in patients with uremic hyperparathyroidism compared with 99mTc-sestaMIBI SPECT/CT and ultrasonography
by: Yu Xue, et al.
Published: (2019-12-01)